Zobrazeno 1 - 10
of 12
pro vyhledávání: '"35"'
Autor:
Ian Naya, Eugene Weinberg
Publikováno v:
Pediatric Allergy and Immunology. 11:49-55
The study objective was to assess whether asthmatic adolescents who were regular users of inhaled corticosteroids preferred treatment with zafirlukast tablets or inhaled beclomethasone dipropionate (BDP), and, secondarily, to assess adolescents' inha
Autor:
Saliha Esenboga, Melike Kahveci, Umit Murat Sahiner, Bulent Enis Sekerel, Betul Karaatmaca, Pınar Gur Cetinkaya, Ozge Soyer, Ayfer Tuncer
Publikováno v:
Pediatric Allergy and Immunology. 31:643-650
BACKGROUND Subcutaneous immunotherapy (SCIT) is the allergen-specific curative treatment of allergic rhinitis. Adverse effects, most of which are local, can be observed during the immunotherapy. These adverse effects have been reported more frequentl
Autor:
A. Wesley Burks, Dominik Reinhold, Matthew Germinaro, Spodra Eglite, Caitlin M.G. McNulty, Werner Braun, Michael D. Kulis, Surendra S. Negi, Jeffery M. Chambliss, Xueni Chen, Stephen C. Dreskin, Brian P. Vickery
Publikováno v:
Pediatr Allergy Immunol
BACKGROUND: For patients with peanut allergy, there are currently no methods to predict who will develop sustained unresponsiveness (SU) after oral immunotherapy (OIT). OBJECTIVE: Assess IgE binding to peanut (PN), Ara h 2 and to specific linear epit
Autor:
Tonje Reier-Nilsen, Karin C. Lødrup Carlsen, Sebastian Drottning, Chi Zhang, Merethe Melbye Michelsen, Magnus P. Borres, Kai-Håkon Carlsen, Geir Håland
Publikováno v:
Pediatric Allergy and Immunology. 30:638-645
BACKGROUND Improved quality of life (QoL) after oral immunotherapy (OIT) in peanut allergic children is often reported by their parents, while the child's perspective is less clear. OBJECTIVE We aimed to explore whether 2 years of OIT improved QoL in
Autor:
Abbas Taghavi Ardakani, Milad Behnejad, Maryam Farrehi, Zatollah Asemi, Davood Kheirkhah, Naghmeh Mirhosseini, Seyed Gholam Abbas Moosavi, Mohammad Reza Sharif, Russel J. Reiter, Vahidreza Ostadmohammadi
Publikováno v:
Pediatric Allergy and Immunology. 29:834-840
Background: The aim of this clinical trial was to determine the effects of melatonin administration on disease severity and sleep quality in children diagnosed with atopic dermatitis (AD). Methods: This randomized, double-blinded, placebo-controlled
Autor:
Kristin Wickens, Gordon Purdie, Peter Abels, Fiona Hood, Penny Fitzharris, Janice Kang, Peter Stone, Robyn Maude, Judy Rowden, Julian Crane, Thorsten Stanley, Christine Barthow, Rinki Murphy, Phillipa Barnes, Isobel K. Franklin, Lieke W J van den Elsen, Edwin A. Mitchell, Elizabeth Forbes-Blom
Publikováno v:
Pediatric Allergy and Immunology. 29:296-302
Background In a randomized placebo-controlled trial, we previously found that the probiotic Lactobacillus rhamnosus HN001 (HN001) taken by mothers from 35 weeks of gestation until 6 months post-partum if breastfeeding and their child from birth to ag
Autor:
Camilla Janefjord, Göran Berg, Leif Matthiesen, Martina Sandberg Abelius, Jan Ernerudh, Maria C. Jenmalm, Malin Jedenfalk
Publikováno v:
Pediatric Allergy and Immunology. 28:818-824
Background: The immunological environment during pregnancy may differ between allergic and non-allergic women. This study investigates the effect of maternal allergy on the allergen-induced cytokine and chemokine levels and whether pregnancy modulate
Autor:
Thanh D. Dang, Katrina J. Allen, David Martino, Mimi L.K. Tang, Paul V. Licciardi, Jennifer J. Koplin
Publikováno v:
Pediatric Allergy and Immunology. 27:35-43
Background Regulatory T cells (Tregs) are critical for development of oral tolerance, and studies suggest that dysfunction of Tregs may lead to food allergy. However, to date, no study has investigated Treg responses following in vivo exposure to pea
Autor:
F. Agostinis, Antonio Barcella, Massimo Milani, Gian Luigi Marseglia, Alessia Marseglia, Amelia Licari, Mario Puviani, Domenico Bonamonte
Publikováno v:
Pediatric Allergy and Immunology
Background A non-steroidal, anti-inflammatory moisturizing cream containing rhamnosoft, ceramides, and L-isoleucine (ILE) (pro-AMP cream) has been recently developed for the specific treatment of atopic eczema (AE) of the face. In this trial, we eval
Autor:
Heikki Hiekkanen, Olli Ruuskanen, Pekka Malmberg, Tytti Vuorinen, Pasi Lehtinen, Tuomas Jartti, Jaakko Hartiala, Mika J. Mäkelä, Timo Vanto
Publikováno v:
Pediatric Allergy and Immunology
Data on the efficacy of corticosteroids on respiratory picornavirus-induced wheezing are limited. To determine whether prednisolone is effective in rhinovirus- or enterovirus-induced recurrent wheezing, we conducted a controlled trial comparing oral